Results 101 to 110 of about 72,448 (283)

Inter‐ and intraspecific variation in theropod dinosaur dental microwear and its palaeoecological implications

The Anatomical Record, EarlyView.
Abstract Differences in skull and tooth morphology, stomach contents, and estimated bite force between medium‐to‐large sized (≥100 kg) predatory theropod dinosaurs have long been suspected to correlate with differences in their diets and dietary guilds (e.g., hypercarnivory, piscivory).
Cassius Morrison, James Gregory, Christopher Jackson, Jordan Bestwick, Katlin Schroeder, Samuel J.L. Gascoigne, Paul Bills, Laura B. Porro, Philip D. Mannion, Paul M. Barrett   +9 more
wiley   +1 more source

Combined Medial Unicompartmental Knee Arthroplasty and Revision Allograft Anterior Cruciate Ligament Reconstruction

Arthroscopy Techniques, EarlyView.
Abstract Combined medial unicompartmental knee arthroplasty and revision anterior cruciate ligament reconstruction with an Achilles tendon allograft offers a promising solution for young, active patients with isolated medial compartment osteoarthritis and a failed prior anterior cruciate ligament reconstruction.
Ryan J. Froom, Alexi J. Panos, Molly E. Kessenich, Nate Dickinson, Mikalyn T. DeFoor, Nathan Cafferky, Matthew T. Provencher   +6 more
wiley   +1 more source

Low-PAPR ASE-DMT Using Constellation Extension for Optical Wireless Communications

Sensors
In the realm of optical wireless communication (OWC), augmented spectral efficiency discrete multitone (ASE-DMT) has been widely recognized as a promising modulation due to its outstanding spectral efficiency and high power efficiency.
Yue Wu, Yiding Li, Baolong Li
doaj   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations

Therapeutic Advances in Neurological Disorders
Background: Treatment guidelines recommend early disease-modifying therapy (DMT) initiation after diagnosis of multiple sclerosis (MS). Multinational comparative studies that assess time to DMT initiation in MS may allow detection of barriers inherent to
Alexander Stahmann, Elaine Craig, David Ellenberger, Firas Fneish, Niklas Frahm, Ruth Ann Marrie, Rod Middleton, Richard Nicholas, Jeff Rodgers, Clemens Warnke, Amber Salter   +10 more
doaj   +1 more source

The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations

British Journal of Clinical Pharmacology, EarlyView.
Spinal muscular atrophy (SMA) is a severe neuromuscular disease with emerging therapeutic complexity. This review aims to systematically map the global pipeline of investigational treatments for SMA. Using ClinicalTrials.gov and complementary international registries, we identified 21 planned or ongoing interventional trials from 2020 to 2025 targeting
Andrej Belančić, Patrick Eustaquio, Elvira Meni Maria Gkrinia, Ivana Stević, Eugen Javor, Yun Wah Lam, Slobodan Janković, Dinko Vitezić   +7 more
wiley   +1 more source

N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer’s disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk

Alzheimer’s Research & Therapy
Background Aberrant neuronal Sigma-1 receptor (Sig-1r)-mediated endoplasmic reticulum (ER)- mitochondria signaling plays a key role in the neuronal cytopathology of Alzheimer’s disease (AD).
Dan Cheng, Zhuo-Gui Lei, Kin Chu, Oi Jin Honey Lam, Chun Yuan Chiang, Zhang-Jin Zhang   +5 more
doaj   +1 more source

Pharmacokinetics and pharmacodynamics of intravenous and oral (S)‐ketamine: Investigating metabolite contribution to subjective effects

British Journal of Clinical Pharmacology, EarlyView.
Aims Oral administration of (S)‐ketamine for treatment‐resistant depression (TRD), as alternative to the registered intranasal or off‐label intravenous administrations, has high potential. However, it is characterized by an extensive first‐pass metabolism, resulting in low (S)‐ketamine exposure and high levels of active metabolites, including (S ...
Marije E. Otto, Gabriël E. Jacobs, Joost C. van Mechelen, Laura G. J. M. Borghans, Johan G. C. van Hasselt, Linda B. S. Aulin   +5 more
wiley   +1 more source

The Theoretical Schema of Dance Movement Therapy: From Medical Body Philosophy to Therapeutic Practice

Yixue yu zhexue
In response to the insufficient theoretical foundation of dance movement therapy (DMT), this study proposes a theoretical schema through interdisciplinary research integrating the philosophy of the medical body and DMT.
Wen LIU, Hong LIU
doaj   +1 more source